Chargement en cours...
Production of Uniform 3D Microtumors in Hydrogel Microwell Arrays for Measurement of Viability, Morphology, and Signaling Pathway Activation
Despite significant investments in cancer research and drug discovery/development, the rate of new cancer drug approval is ≤5% and most cases of metastatic cancer remain incurable. Ninety-five percent of new cancer drugs fail in clinical development because of a lack of therapeutic efficacy and/or u...
Enregistré dans:
| Publié dans: | Assay Drug Dev Technol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Mary Ann Liebert, Inc.
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4652144/ https://ncbi.nlm.nih.gov/pubmed/26274587 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/adt.2015.662 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|